Xolair
Mar 01, 2024
Revolutionizing the Food Allergy Treatment: The Impact of Xolair’s Approval
Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
